{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:58:35Z","timestamp":1790305115006,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Provincial Training Program for Innovation and Entrepreneurship of College Students of Chengdu University","award":["S202611079027X"],"award-info":[{"award-number":["S202611079027X"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-06185-5","type":"journal-article","created":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T14:15:17Z","timestamp":1783260917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of higher-dose versus lower-dose corticosteroids in community-acquired pneumonia: a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"30","author":[{"given":"Yikang","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangchun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,5]]},"reference":[{"issue":"10517","key":"6185_CR1","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/S0140-6736(25)01493-X","volume":"406","author":"LF Reyes","year":"2025","unstructured":"Reyes LF, Conway Morris A, Serrano-Mayorga C, Derde LPG, Dickson RP, Martin-Loeches I. Community-acquired pneumonia. Lancet. 2025;406(10517):2371\u201388.","journal-title":"Lancet"},{"issue":"15","key":"6185_CR2","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/jama.2024.14796","volume":"332","author":"VM Vaughn","year":"2024","unstructured":"Vaughn VM, Dickson RP, Horowitz JK, Flanders SA. Community-Acquired Pneumonia: A Review. JAMA. 2024;332(15):1282\u201395.","journal-title":"JAMA"},{"issue":"21","key":"6185_CR3","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"PF Dequin","year":"2023","unstructured":"Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, et al. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med. 2023;388(21):1931\u201341.","journal-title":"N Engl J Med"},{"issue":"5","key":"6185_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.resinv.2025.06.014","volume":"63","author":"H Mukae","year":"2025","unstructured":"Mukae H, Iwanaga N, Horita N, Komiya K, Maruyama T, Shindo Y, et al. The JRS guideline for the management of pneumonia in adults 2024. Respir Investig. 2025;63(5):811\u201328.","journal-title":"Respir Investig"},{"key":"6185_CR5","doi-asserted-by":"crossref","unstructured":"Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Eur Respir J. 2023;61(4): 2200735.","DOI":"10.1183\/13993003.00735-2022"},{"issue":"5","key":"6185_CR6","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","volume":"52","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena R, et al. 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia. Crit Care Med. 2024;52(5):e219\u201333.","journal-title":"Crit Care Med"},{"issue":"2","key":"6185_CR7","doi-asserted-by":"publisher","first-page":"105034","DOI":"10.1016\/j.idnow.2025.105034","volume":"55","author":"A Dinh","year":"2025","unstructured":"Dinh A, Barbier F, Bedos J-P, Blot M, Cattoir V, Claessens Y-E, et al. Update of guidelines for management of community acquired pneumonia in adults by the French infectious disease society (SPILF) and the French-speaking society of respiratory diseases (SPLF). Endorsed by the French intensive care society (SRLF), the French microbiology society (SFM), the French radiology society (SFR) and the French emergency society (SFMU). Infect Dis Now. 2025;55(2):105034.","journal-title":"Infect Dis Now"},{"issue":"1","key":"6185_CR8","first-page":"24","volume":"212","author":"BE Jones","year":"2026","unstructured":"Jones BE, Ramirez JA, Oren E, Soni NJ, Sullivan LR, Restrepo MI, et al. Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2026;212(1):24\u201344.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"6185_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/17511437251330145","volume":"26","author":"I Terrington","year":"2025","unstructured":"Terrington I, Cox O, Webb E, Eastwood B, Copley P, Saeed K, et al. Corticosteroids for the management of severe community-acquired pneumonia: A UK-wide survey. J Intensive Care Soc. 2025;26(3):396\u20139.","journal-title":"J Intensive Care Soc"},{"issue":"1","key":"6185_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40560-025-00809-8","volume":"13","author":"S Fujishima","year":"2025","unstructured":"Fujishima S. Current corticosteroid therapeutic strategy for community-acquired pneumonia in adults: indications, dosage, and timing. J Intensive Care. 2025;13(1):37.","journal-title":"J Intensive Care"},{"issue":"1","key":"6185_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12877-025-05852-6","volume":"25","author":"M Ali","year":"2025","unstructured":"Ali M, Liu J, Zheng Y, Chen J, He Z, Jiang X, et al. Efficacy and safety of glucocorticoids therapy of severe community-acquired pneumonia in older adults: a systematic review and meta-analysis. BMC Geriatr. 2025;25(1):225.","journal-title":"BMC Geriatr"},{"key":"6185_CR12","doi-asserted-by":"crossref","unstructured":"See XY, Wang TH, Chang YC, Lo J, Liu W, Choo CYW et al. Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis. BMJ Open Respir Res. 2024;11(1):e002141.","DOI":"10.1136\/bmjresp-2023-002141"},{"key":"6185_CR13","doi-asserted-by":"publisher","first-page":"1479804","DOI":"10.3389\/fphar.2024.1479804","volume":"15","author":"P Wang","year":"2024","unstructured":"Wang P, Wan J, You Q, Zheng Y, Xu W, He J, et al. Association between various types of corticosteroids and mortality for severe community-acquired pneumonia in adults: a systematic review and network meta-analysis. Front Pharmacol. 2024;15:1479804.","journal-title":"Front Pharmacol"},{"issue":"11","key":"6185_CR14","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1007\/s11606-023-08203-6","volume":"38","author":"T Pitre","year":"2023","unstructured":"Pitre T, Abdali D, Chaudhuri D, Pastores SM, Nei AM, Annane D, et al. Corticosteroids in Community-Acquired Bacterial Pneumonia: a Systematic Review, Pairwise and Dose-Response Meta-Analysis. J Gen Intern Med. 2023;38(11):2593\u2013606.","journal-title":"J Gen Intern Med"},{"issue":"12","key":"6185_CR15","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/cid\/ciad496","volume":"77","author":"F Bergmann","year":"2023","unstructured":"Bergmann F, Pracher L, Sawodny R, Blaschke A, Gelbenegger G, Radtke C, et al. Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials. Clin Infect diseases: official publication Infect Dis Soc Am. 2023;77(12):1704\u201313.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"},{"key":"6185_CR16","doi-asserted-by":"publisher","first-page":"154507","DOI":"10.1016\/j.jcrc.2023.154507","volume":"80","author":"HA Cheema","year":"2024","unstructured":"Cheema HA, Musheer A, Ejaz A, Paracha AA, Shahid A, Rehman MEU, et al. Efficacy and safety of corticosteroids for the treatment of community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials. J Crit Care. 2024;80:154507.","journal-title":"J Crit Care"},{"key":"6185_CR17","doi-asserted-by":"publisher","first-page":"109389","DOI":"10.1016\/j.steroids.2024.109389","volume":"205","author":"LA Diaz Caballero","year":"2024","unstructured":"Diaz Caballero LA, Aijaz A, Saleem Paryani N, Mahmood S, Salman M, Omer Khan M, et al. Comparing the efficacy of corticosteroids among patients with community-acquired pneumonia in the ICU versus non-ICU settings: A systematic review and meta-analysis. Steroids. 2024;205:109389.","journal-title":"Steroids"},{"issue":"3","key":"6185_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.chest.2022.08.2229","volume":"163","author":"N Saleem","year":"2023","unstructured":"Saleem N, Kulkarni A, Snow TAC, Ambler G, Singer M, Arulkumaran N. Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia: A Systematic Review, Meta-analysis, and Meta-regression of Randomized Control Trials. Chest. 2023;163(3):484\u201397.","journal-title":"Chest"},{"issue":"1","key":"6185_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13054-023-04561-z","volume":"27","author":"JY Wu","year":"2023","unstructured":"Wu JY, Tsai YW, Hsu WH, Liu TH, Huang PY, Chuang MH, et al. Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials. Crit Care (London England). 2023;27(1):274.","journal-title":"Crit Care (London England)"},{"issue":"175","key":"6185_CR20","doi-asserted-by":"publisher","first-page":"240131","DOI":"10.1183\/16000617.0131-2024","volume":"34","author":"FV Piedepalumbo","year":"2025","unstructured":"Piedepalumbo FV, Motos A, Blasi F, Torres A. Safety of steroids in severe community-acquired pneumonia. Eur Respiratory Rev. 2025;34(175):240131.","journal-title":"Eur Respiratory Rev"},{"issue":"3","key":"6185_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/cid\/cix801","volume":"66","author":"M Briel","year":"2018","unstructured":"Briel M, Spoorenberg SMC, Snijders D, Torres A, Fernandez-Serrano S, Meduri GU, et al. Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis. Clin Infect Dis. 2018;66(3):346\u201354.","journal-title":"Clin Infect Dis"},{"key":"6185_CR22","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"11","key":"6185_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"issue":"5","key":"6185_CR24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00134-025-07912-2","volume":"51","author":"T Pitre","year":"2025","unstructured":"Pitre T, Pauley E, Chaudhuri D, Saha R, Rudd KE, Villar J, et al. Corticosteroids for adult patients hospitalised with non-viral community-acquired pneumonia: a systematic review and meta-analysis. Intensive Care Med. 2025;51(5):917\u201329.","journal-title":"Intensive Care Med"},{"issue":"2","key":"6185_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","volume":"63","author":"AW Meikle","year":"1977","unstructured":"Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977;63(2):200\u20137.","journal-title":"Am J Med"},{"issue":"1","key":"6185_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","volume":"44","author":"D Czock","year":"2005","unstructured":"Czock D, Keller F, Rasche FM, H\u00e4ussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61\u201398.","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"6185_CR27","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143.","journal-title":"Crit Care Med"},{"key":"6185_CR28","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"issue":"2","key":"6185_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v106.i02","volume":"106","author":"S Balduzzi","year":"2023","unstructured":"Balduzzi S, R\u00fccker G, Nikolakopoulou A, Papakonstantinou T, Salanti G, Efthimiou O, Schwarzer G. netmeta: An R Package for Network Meta-Analysis Using Frequentist Methods. J Stat Softw. 2023;106(2):1\u201340.","journal-title":"J Stat Softw"},{"key":"6185_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","volume":"14","author":"J IntHout","year":"2014","unstructured":"IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14:25.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"6185_CR31","first-page":"cl21080","volume":"16","author":"T Papakonstantinou","year":"2020","unstructured":"Papakonstantinou T, Nikolakopoulou A, Higgins JPT, Egger M, Salanti G. CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis. Campbell Syst Reviews. 2020;16(1):cl21080.","journal-title":"Campbell Syst Reviews"},{"issue":"4","key":"6185_CR32","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","volume":"17","author":"A Nikolakopoulou","year":"2020","unstructured":"Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M, Salanti G. CINeMA: An approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020;17(4):e1003082.","journal-title":"PLoS Med"},{"issue":"4","key":"6185_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00134-025-07861-w","volume":"51","author":"DC Angus","year":"2025","unstructured":"Angus DC. Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia: The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial. Intensive Care Med. 2025;51(4):665\u201380.","journal-title":"Intensive Care Med"},{"issue":"1","key":"6185_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.CCM.0000194723.78632.62","volume":"34","author":"D Annane","year":"2006","unstructured":"Annane D, S\u00e9bille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med. 2006;34(1):22\u201330.","journal-title":"Crit Care Med"},{"issue":"9977","key":"6185_CR35","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","volume":"385","author":"CA Blum","year":"2015","unstructured":"Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I, et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2015;385(9977):1511\u20138.","journal-title":"Lancet"},{"issue":"3","key":"6185_CR36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","volume":"171","author":"M Confalonieri","year":"2005","unstructured":"Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171(3):242\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"6185_CR37","first-page":"91","volume":"55","author":"A El-Ghamrawy","year":"2006","unstructured":"El-Ghamrawy A, Shokeir M, Esmat A. Effects of low-dose hydrocortisone in ICU patients with severe community-acquired pneumonia. Egypt J Chest. 2006;55:91\u20139.","journal-title":"Egypt J Chest"},{"issue":"2","key":"6185_CR38","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/cc10103","volume":"15","author":"S Fern\u00e1ndez-Serrano","year":"2011","unstructured":"Fern\u00e1ndez-Serrano S, Dorca J, Garcia-Vidal C, Fern\u00e1ndez-Sab\u00e9 N, Carratal\u00e0 J, Fern\u00e1ndez-Ag\u00fcera A, et al. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care (London England). 2011;15(2):R96.","journal-title":"Crit Care (London England)"},{"issue":"5","key":"6185_CR39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. JAMA. 2016;316(5):509\u201318.","journal-title":"JAMA"},{"issue":"5","key":"6185_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S2213-2600(23)00430-7","volume":"12","author":"N Heming","year":"2024","unstructured":"Heming N, Renault A, Kuperminc E, Brun-Buisson C, Megarbane B, Quenot JP, et al. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial. Lancet Respir Med. 2024;12(5):366\u201374.","journal-title":"Lancet Respir Med"},{"issue":"17","key":"6185_CR41","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.2016.14799","volume":"316","author":"D Keh","year":"2016","unstructured":"Keh D, Trips E, Marx G, Wirtz SP, Abduljawwad E, Bercker S, et al. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial. JAMA. 2016;316(17):1775\u201385.","journal-title":"JAMA"},{"issue":"9","key":"6185_CR42","first-page":"780","volume":"28","author":"G Li","year":"2016","unstructured":"Li G, Gu C, Zhang S, Lian R, Zhang G. Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock. Chin Crit Care Med. 2016;28(9):780\u20134.","journal-title":"Chin Crit Care Med"},{"issue":"8","key":"6185_CR43","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1001\/jamainternmed.2019.1438","volume":"179","author":"M Lloyd","year":"2019","unstructured":"Lloyd M, Karahalios A, Janus E, Skinner EH, Haines T, De Silva A, et al. Effectiveness of a Bundled Intervention Including Adjunctive Corticosteroids on Outcomes of Hospitalized Patients With Community-Acquired Pneumonia: A Stepped-Wedge Randomized Clinical Trial. JAMA Intern Med. 2019;179(8):1052\u201360.","journal-title":"JAMA Intern Med"},{"key":"6185_CR44","doi-asserted-by":"crossref","unstructured":"Lucinde RK, Gathuri H, Mwaniki P, Orindi B, Otieno EO, Mwakio S et al. A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia. N Engl J Med. 2025;393(22):2187-2197.","DOI":"10.1056\/NEJMoa2507100"},{"issue":"2","key":"6185_CR45","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1378\/chest.104.2.389","volume":"104","author":"P Marik","year":"1993","unstructured":"Marik P, Kraus P, Sribante J, Havlik I, Lipman J, Johnson DW. Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study. Chest. 1993;104(2):389\u201392.","journal-title":"Chest"},{"issue":"5840","key":"6185_CR46","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bmj.4.5840.569","volume":"4","author":"VU McHardy","year":"1972","unstructured":"McHardy VU, Schonell ME. Ampicillin dosage and use of prednisolone in treatment of pneumonia: co-operative controlled trial. Br Med J. 1972;4(5840):569\u201373.","journal-title":"Br Med J"},{"issue":"4","key":"6185_CR47","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1378\/chest.06-2100","volume":"131","author":"GU Meduri","year":"2007","unstructured":"Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131(4):954\u201363.","journal-title":"Chest"},{"issue":"2","key":"6185_CR48","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/jama.280.2.159","volume":"280","author":"GU Meduri","year":"1998","unstructured":"Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280(2):159\u201365.","journal-title":"JAMA"},{"issue":"8","key":"6185_CR49","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","volume":"48","author":"GU Meduri","year":"2022","unstructured":"Meduri GU, Shih MC, Bridges L, Martin TJ, El-Solh A, Seam N, et al. Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med. 2022;48(8):1009\u201323.","journal-title":"Intensive Care Med"},{"issue":"9782","key":"6185_CR50","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","volume":"377","author":"SC Meijvis","year":"2011","unstructured":"Meijvis SC, Hardeman H, Remmelts HH, Heijligenberg R, Rijkers GT, van Velzen-Blad H, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377(9782):2023\u201330.","journal-title":"Lancet"},{"issue":"5","key":"6185_CR51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00408-007-9020-3","volume":"185","author":"K Mikami","year":"2007","unstructured":"Mikami K, Suzuki M, Kitagawa H, Kawakami M, Hirota N, Yamaguchi H, et al. Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung. 2007;185(5):249\u201355.","journal-title":"Lung"},{"issue":"3","key":"6185_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejcdt.2013.03.009","volume":"62","author":"RM Nafae","year":"2013","unstructured":"Nafae RM, Ragab MI, Amany FM, Rashed SB. Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia. Egypt J Chest Dis Tuberculosis. 2013;62(3):439\u201345.","journal-title":"Egypt J Chest Dis Tuberculosis"},{"issue":"1","key":"6185_CR53","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejcdt.2013.02.013","volume":"62","author":"NA Rezk","year":"2013","unstructured":"Rezk NA, Ibrahim AM. Effects of methyl prednisolone in early ARDS. Egypt J Chest Dis Tuberculosis. 2013;62(1):167\u201372.","journal-title":"Egypt J Chest Dis Tuberculosis"},{"issue":"02","key":"6185_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4236\/pp.2011.22009","volume":"2","author":"NA Sabry","year":"2011","unstructured":"Sabry NA, Omar EE-D. Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacol Pharm. 2011;2(02):73\u201381.","journal-title":"Pharmacol Pharm"},{"issue":"9","key":"6185_CR55","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","volume":"181","author":"D Snijders","year":"2010","unstructured":"Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med. 2010;181(9):975\u201382.","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"6185_CR56","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa051693","volume":"354","author":"KP Steinberg","year":"2006","unstructured":"Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671\u201384.","journal-title":"N Engl J Med"},{"issue":"1","key":"6185_CR57","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","volume":"20","author":"S Tongyoo","year":"2016","unstructured":"Tongyoo S, Permpikul C, Mongkolpun W, Vattanavanit V, Udompanturak S, Kocak M, Meduri GU. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care (London England). 2016;20(1):329.","journal-title":"Crit Care (London England)"},{"issue":"7","key":"6185_CR58","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.2015.88","volume":"313","author":"A Torres","year":"2015","unstructured":"Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313(7):677\u201386.","journal-title":"JAMA"},{"issue":"9","key":"6185_CR59","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med. 2018;378(9):797\u2013808.","journal-title":"N Engl J Med"},{"issue":"3","key":"6185_CR60","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar J, Ferrando C, Mart\u00ednez D, Ambr\u00f3s A, Mu\u00f1oz T, Soler JA, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267\u201376.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"6185_CR61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4103\/ejcdt.ejcdt_39_20","volume":"70","author":"S Wafy","year":"2021","unstructured":"Wafy S, Bayoumi H, El-Naser SA. Adding steroids in severe community-acquired pneumonia treatment: does it make a difference? Egypt J Chest Dis Tuberculosis. 2021;70(1):71\u20137.","journal-title":"Egypt J Chest Dis Tuberculosis"},{"issue":"3","key":"6185_CR62","first-page":"197","volume":"98","author":"HN Wagner Jr","year":"1956","unstructured":"Wagner HN Jr., Bennett IL Jr., Lasagna L, Cluff LE, Rosenthal MB, Mirick GS. The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin. Bull Johns Hopkins Hosp. 1956;98(3):197\u2013215.","journal-title":"Bull Johns Hopkins Hosp"},{"key":"6185_CR63","doi-asserted-by":"crossref","unstructured":"Wittermans E, Vestjens SMT, Spoorenberg SMC, Blok WL, Grutters JC, Janssen R et al. Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial. Eur Respir J. 2021;58(2):2002535.","DOI":"10.1183\/13993003.02535-2020"},{"issue":"4","key":"6185_CR64","first-page":"e1071","volume":"6","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Israelian L, Putowski Z, Prakash J, Pitre T, Nei AM, et al. Adverse Effects Related to Corticosteroid Use in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis. Crit Care Explor. 2024;6(4):e1071.","journal-title":"Crit Care Explor"},{"issue":"12","key":"6185_CR65","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1007\/s00125-016-4091-4","volume":"59","author":"M Popovic","year":"2016","unstructured":"Popovic M, Blum CA, Nigro N, Mueller B, Schuetz P, Christ-Crain M. Benefit of adjunct corticosteroids for community-acquired pneumonia in diabetic patients. Diabetologia. 2016;59(12):2552\u201360.","journal-title":"Diabetologia"},{"key":"6185_CR66","unstructured":"Randomized E. Multifactorial, Adaptive Platform Trial of Pathogen-Directed Precision Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia(Core Protocal) [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07152587"},{"issue":"3","key":"6185_CR67","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-2600(24)00405-3","volume":"13","author":"JM Smit","year":"2025","unstructured":"Smit JM, Van Der Zee PA, Stoof SCM, Van Genderen ME, Snijders D, Boersma WG, et al. Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials. Lancet Respir Med. 2025;13(3):221\u201333.","journal-title":"Lancet Respir Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06185-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06185-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06185-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:02:12Z","timestamp":1790301732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06185-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,5]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6185"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06185-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,5]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study is a systematic review and network meta-analysis of published aggregate data and did not involve new recruitment of human participants, human tissue, or individual patient data.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"494"}}